Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?

BACKGROUND: Neoadjuvant chemotherapy (NAC) followed by surgery currently offers promise as a strategy for patients with locally advanced gastric cancer (GC). However, there is limited evidence to guide treatment for TRG 0 and 1 patients with locally advanced GC after R0 resection. This study set out...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Fei, Zhang, Yonglei, Peng, Liangqun, Zhang, Zhandong, Yang, Wei, Chai, Junhui, Zhang, Bin, Ji, Sheqing, Hua, Yawei, Chen, Xiaobing, Luo, Suxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475443/
https://www.ncbi.nlm.nih.gov/pubmed/32953748
http://dx.doi.org/10.21037/atm-20-3986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475443/
https://www.ncbi.nlm.nih.gov/pubmed/32953748
http://dx.doi.org/10.21037/atm-20-3986

Ejemplares similares